Effects of Glaucoma Medications on Corneal Endothelium, Keratocytes, and Subbasal Nerves Among Participants in the Ocular Hypertension Treatment Study-Reference-Cited by-同舟云学术

Effects of Glaucoma Medications on Corneal Endothelium, Keratocytes, and Subbasal Nerves Among Participants in the Ocular Hypertension Treatment Study

Published:2006-10 Issue:9 Volume:25 Page:1046-1052
ISSN:0277-3740
Container-title:Cornea
language:en
Short-container-title:

Author:

Baratz Keith H,Nau Cherie B,Winter Eric J,McLaren Jay W,Hodge David O,Herman David C,Bourne William M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

Reference49 articles.

1. Corneal and conjunctival changes caused by commonly used glaucoma medications.;Noecker;Cornea,2004

2. Effects of antiglaucoma drugs on ocular surface.;Yalvac;Acta Ophthalmol Scand,1995

3. Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v. 0.12% unoprostone.;Shimazaki;Br J Ophthalmol,2000

4. Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension.;Thygesen;Acta Ophthalmol Scand,2000

5. Ocular surface alteration after long-term treatment with an antiglaucomatous drug.;Herreras;Ophthalmology,1992

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To Assess and Compare the Effect of Combination of Anti-Glaucoma Drug on Corneal Endothelium in Primary Glaucoma Patients with Age Matched Healthy Control;Journal of Ophthalmology and Advance Research;2024-07-31

2. Corneal endothelial cells survival rate in primary open angle glaucoma eyes after cataract surgery. (Review);Journal of Clinical Practice;2024-06-22

3. A Narrative Review of Pharmacotherapy of Glaucoma;Future Pharmacology;2024-05-27

4. Effect of Topical Recombinant Human Nerve Growth Factor on Corneal Epithelial Regeneration in Refractory Epithelial Keratopathy;Ocular Immunology and Inflammation;2024-03

5. Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions;Pharmaceuticals;2023-07-24